Collaborative Action and Research for Engagement, Persistence and Adherence in Treatment & Health

HealthHORIZON-JU-RIAID: 101192133
EC Contribution
โ‚ฌ113,000
Consortium Size
41 orgs
Start Year
2025
โ–ถSummary

CAREPATH aims to improve chronic disease management and medication persistence by transforming the care ecosystem, ensuring personalised support for better health outcomes, and reducing healthcare costs. We focus on improving medication adherence and persistence for three prevalent chronic conditions: Obesity (BMI โ‰ฅ 30 kg/m2), Type 2 Diabetes Mellitus (T2DM), and cardiovascular diseases (CVD), including chronic heart failure (CHF), across six diverse European countries: Germany, Israel, the Netherlands, Poland, Spain, and Sweden. These countries represent various EU healthcare environments and economic statuses, emphasising the need for tailored approaches to patient care.Our strategy involves integrating localised non-digital and digital health solutions to address the unique healthcare delivery challenges in each region. The CAREPATH toolbox collects, combines, and customises existing solutions into adaptable modules for broad application in both primary and secondary care settings. This toolbox will be tested in four studies across two settings in all six countries in both primary and secondary care. Three pilot studies in different regions as well as a proof-of-concept study in Germany will be conducted. This comprehensive evaluation, including HTA, aims to assess the toolbox's implementation and effectiveness, with a strong focus on learning what works for what groups of patients in which setting.Recognizing the significant impact of obesity, particular emphasis is placed on treatment adherence and persistence of medications that facilitate weight loss, such as dual GIP/GLP-1 receptor agonists, but CAREPATH studies also include patients using lipid-lowering drugs, insulin, and SGLT2 inhibitors. Our goal is to empower patients by improving communication and data sharing among patients, healthcare providers, and other stakeholders, thereby supporting the entire ecosystem and alleviating the burden on healthcare systems.

Consortium (41)

๐Ÿ‡ธ๐Ÿ‡ช RISE RESEARCH INSTITUTES OF SWEDEN ABSE
coordinator
๐Ÿ‡ฎ๐Ÿ‡น A. MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE SRLIT
partner
๐Ÿ‡ฉ๐Ÿ‡ช ABBOTT GMBHDE
partner
๐Ÿ‡ณ๐Ÿ‡ฑ ACADEMISCH ZIEKENHUIS GRONINGENNL
partner
๐Ÿ‡ช๐Ÿ‡ธ Asociaciรณn Bariรกtrica Hรญspalis NacionalES
partner
๐Ÿ‡ฎ๐Ÿ‡ฑ BAR ILAN UNIVERSITYIL
partner
๐Ÿ‡ซ๐Ÿ‡ท BIOCORP PRODUCTIONFR
partner
๐Ÿ‡ฉ๐Ÿ‡ช CHARITE - UNIVERSITAETSMEDIZIN BERLINDE
partner
๐Ÿ‡บ๐Ÿ‡ธ ELI LILLY AND COMPANYUS
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACIO INSTITUT D'INVESTIGACIO SANITARIA ILLES BALEARSES
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINAES
partner
๐Ÿ‡ฉ๐Ÿ‡ช HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBHDE
partner
๐Ÿ‡ง๐Ÿ‡ช HL7 EUROPEBE
partner
๐Ÿ‡ณ๐Ÿ‡ฑ Imagine AI B.V.NL
partner
๐Ÿ‡ช๐Ÿ‡ธ INSTITUT CATALA DE LA SALUTES
partner
๐Ÿ‡ช๐Ÿ‡ธ INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOLES
partner
๐Ÿ‡ซ๐Ÿ‡ท INSTITUT DE RECHERCHES INTERNATIONALES SERVIERFR
partner
๐Ÿ‡จ๐Ÿ‡ญ IQVIA AGCH
partner
๐Ÿ‡ฎ๐Ÿ‡ฑ ISRAEL DIABETES ASSOCIATIONIL
partner
๐Ÿ‡ฉ๐Ÿ‡ช LANDSCHAFTSVERBAND RHEINLANDDE
partner
๐Ÿ‡ฉ๐Ÿ‡ช Lilly Deutschland GmbHDE
partner
๐Ÿ‡ซ๐Ÿ‡ท Lilly FranceFR
partner
๐Ÿ‡ณ๐Ÿ‡ฑ MAMA PRODUCTIES BVNL
partner
๐Ÿ‡ง๐Ÿ‡ช MENARINI BENELUXBE
partner
๐Ÿ‡ฎ๐Ÿ‡น MENARINI RICERCHE SPAIT
partner
๐Ÿ‡ฉ๐Ÿ‡ฐ NOVO NORDISK A/SDK
partner
๐Ÿ‡ต๐Ÿ‡ฑ Ogolnopolskie Stowarzyszenie Pacjentow ze Schorzeniami Serca i Naczyn EcosercePL
partner
๐Ÿ‡บ๐Ÿ‡ธ PFIZER INCUS
partner
๐Ÿ‡ฌ๐Ÿ‡ง PFIZER LIMITEDGB
partner
๐Ÿ‡ฌ๐Ÿ‡ง Pfizer R&D UK LimitedGB
partner
๐Ÿ‡ช๐Ÿ‡ธ Pfizer SLUES
partner
๐Ÿ‡ณ๐Ÿ‡ฑ RIJKSUNIVERSITEIT GRONINGENNL
partner
๐Ÿ‡ธ๐Ÿ‡ช Riksforbundet HjartLungSE
partner
๐Ÿ‡ณ๐Ÿ‡ฑ STICHTING AMSTERDAM UMCNL
partner
๐Ÿ‡ณ๐Ÿ‡ฑ STICHTING VUNL
partner
๐Ÿ‡ต๐Ÿ‡ฑ Thaumatec SP ZOOPL
partner
๐Ÿ‡ฎ๐Ÿ‡ช THE EUROPEAN COALITION FOR PEOPLE LIVING WITH OBESITY COMPANY LIMITED BY GUARANTEEIE
partner
๐Ÿ‡ฉ๐Ÿ‡ช UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITATDE
partner
๐Ÿ‡ต๐Ÿ‡ฑ UNIWERSYTET MEDYCZNY W LODZIPL
partner
๐Ÿ‡ธ๐Ÿ‡ช VASTRA GOTALANDSREGIONENSE
partner
๐Ÿ‡ณ๐Ÿ‡ฑ WAVY ASSISTANT BVNL
partner